![](/img/cover-not-exists.png)
F39Safety of Eribulin plus Trastuzumab in pre-treated HER2-positive advanced breast cancer (ABC) patients: results from an Italian observational study
Orlando, L., Lutrino, E.S., Giordano, G., Zamagni, C., Caliolo, C., Febbraro, A., Giampaglia, M., Dima, G., Rubino, D., Scavelli, C., Schiavone, P., Bilancia, D., Filippelli, G., Quaranta, A., Fedele,Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw337.39
Date:
September, 2016
File:
PDF, 64 KB
2016